RecruitingPhase 4NCT05551299
Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
Studying Perihilar cholangiocarcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Leipzig
- Principal Investigator
- Albrecht Hoffmeister, Prof.Dr.med.Universitätsklinikum Leipzig; Bereich Gastroenterologie
- Intervention
- Photosensitizer(drug)
- Enrollment
- 258 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2028
Study locations (20)
- Uniklinik RWTH Aachen, Medizinische Klinik III, Aachen, Germany
- Universitätsklinikum Augsburg; III. Med. Klinik, Augsburg, Germany
- Vivantes Netzwerk für Gesundheit GmbH, Klinikum Friedrichshain, Innere Medizin/Gastroenterologie, Berlin, Germany
- Universitatsklinikum Bonn, Medizinische Klinik und Poliklinik I, Bonn, Germany
- Universitätsklinikum Frankfurt, Medizinische Klinik 1, Frankfurt, Germany
- Universitätsklinikum Freiburg, Medizinische Klinik II, Abteilung Gastroenterologie, Hepatologie, Endokrinologie & lnfektiologie, Freiburg im Breisgau, Germany
- Universitätsmedizin Greifswald Klinik für Innere Medizin A, Greifswald, Germany
- Site: Martin-Luther-Universitat Halle-Wittenberg, Universitätsklinik und Poliklinik für Innere Medizin I, Halle, Germany
- Klinikum Hanau; Klinik für Gastroenterologie, Diabetologie und Infektiologie, Hanau, Germany
- KRH Klinikum Siloah, Klinik für Gastroenterologie, Hanover, Germany
- Klinikum St. Georg gGmbH; Klinik für Gastroenterologie, Hepatologie, Diabetologie und Endokrinologie, Leipzig, Germany
- University Hospital of Leipzig, Department of Gastroenterology, Leipzig, Germany
- RKH Kliniken Ludwigsburg- Bietigheim gGmbH, Klinik für Innere Medizin, Gastroenterologie, Hämato-Onkologie, Diabetologie und Infektiologie, Ludwigsburg, Germany
- Universitätsmedizin Mannheim, II. Medizinische Klinik, Mannheim, Germany
- Universitätsklinikum Gießen und Marburg GmbH (UKGM); Klinik für Innere Medizin mit den Schwerpunkten Gastroenterologie, Endokrinologie, Stoffwechsel und klinische Infektiologie, Marburg, Germany
- +5 more locations on ClinicalTrials.gov
Collaborators
Zentrum für Klinische Studien Leipzig
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05551299 on ClinicalTrials.govOther trials for Perihilar cholangiocarcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06986486Liver Transplantation for Unresectable Perihilar CholangiocarcinomaFondazione IRCCS Istituto Nazionale dei Tumori, Milano
- RECRUITINGNANCT06850753En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant CriteriaOslo University Hospital
- ACTIVE NOT RECRUITINGPHASE2NCT06717464Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract CancerTianjin Medical University Cancer Institute and Hospital
- RECRUITINGNANCT06493734Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar CholangiocarcinomaErasmus Medical Center
- ACTIVE NOT RECRUITINGPHASE2NCT05564403Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)National Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGPHASE2NCT06178588Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic CholangiocarcinomaUniversity of Kansas Medical Center
- RECRUITINGNANCT06125769LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)Azienda Sanitaria Ospedaliera
- RECRUITINGNANCT06964425Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot StudyUniversity Hospital Olomouc